Table of Contents

1 Study Coverage

• 1.1 Antifungal Therapeutics Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Antifungal Therapeutics Market Size Growth Rate by Product
  • 1.4.2 Echinacea
  • 1.4.3 Polyene
  • 1.4.4 Pyrimidines
  • 1.4.5 Other
• 1.5 Market by End User
  • 1.5.1 Global Antifungal Therapeutics Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Clinic
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Antifungal Therapeutics Market Size
  • 2.1.1 Global Antifungal Therapeutics Revenue 2014-2025
  • 2.1.2 Global Antifungal Therapeutics Sales 2014-2025
• 2.2 Antifungal Therapeutics Growth Rate by Regions
  • 2.2.1 Global Antifungal Therapeutics Sales by Regions
  • 2.2.2 Global Antifungal Therapeutics Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Antifungal Therapeutics Sales by Manufacturers
  • 3.1.1 Antifungal Therapeutics Sales by Manufacturers
  • 3.1.2 Antifungal Therapeutics Sales Market Share by Manufacturers
  • 3.1.3 Global Antifungal Therapeutics Market Concentration Ratio (CR5 and HHI)
• 3.2 Antifungal Therapeutics Revenue by Manufacturers
  • 3.2.1 Antifungal Therapeutics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Antifungal Therapeutics Revenue Share by Manufacturers (2014-2019)
• 3.3 Antifungal Therapeutics Price by Manufacturers
• 3.4 Antifungal Therapeutics Manufacturing Base Distribution, Product Types
  • 3.4.1 Antifungal Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Antifungal Therapeutics Product Type
  • 3.4.3 Date of International Manufacturers Enter into Antifungal Therapeutics Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Antifungal Therapeutics Sales by Product
• 4.2 Global Antifungal Therapeutics Revenue by Product
• 4.3 Antifungal Therapeutics Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Antifungal Therapeutics Breakdown Data by End User

6 North America

• 6.1 North America Antifungal Therapeutics by Countries
  • 6.1.1 North America Antifungal Therapeutics Sales by Countries
  • 6.1.2 North America Antifungal Therapeutics Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Antifungal Therapeutics by Product
• 6.3 North America Antifungal Therapeutics by End User

7 Europe

• 7.1 Europe Antifungal Therapeutics by Countries
  • 7.1.1 Europe Antifungal Therapeutics Sales by Countries
  • 7.1.2 Europe Antifungal Therapeutics Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Antifungal Therapeutics by Product
• 7.3 Europe Antifungal Therapeutics by End User

8 Asia Pacific

• 8.1 Asia Pacific Antifungal Therapeutics by Countries
  • 8.1.1 Asia Pacific Antifungal Therapeutics Sales by Countries
  • 8.1.2 Asia Pacific Antifungal Therapeutics Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Antifungal Therapeutics by Product
• 8.3 Asia Pacific Antifungal Therapeutics by End User

9 Central & South America

• 9.1 Central & South America Antifungal Therapeutics by Countries
  • 9.1.1 Central & South America Antifungal Therapeutics Sales by Countries
  • 9.1.2 Central & South America Antifungal Therapeutics Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Antifungal Therapeutics by Product
• 9.3 Central & South America Antifungal Therapeutics by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Antifungal Therapeutics by Countries
  • 10.1.1 Middle East and Africa Antifungal Therapeutics Sales by Countries
  • 10.1.2 Middle East and Africa Antifungal Therapeutics Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Antifungal Therapeutics by Product
• 10.3 Middle East and Africa Antifungal Therapeutics by End User

11 Company Profiles

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Pfizer Antifungal Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Pfizer Antifungal Therapeutics Products Offered
  • 11.1.5 Pfizer Recent Development
• 11.2 Merck
  • 11.2.1 Merck Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Merck Antifungal Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Merck Antifungal Therapeutics Products Offered
  • 11.2.5 Merck Recent Development
• 11.3 GSK
  • 11.3.1 GSK Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 GSK Antifungal Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 GSK Antifungal Therapeutics Products Offered
  • 11.3.5 GSK Recent Development
• 11.4 Novartis
  • 11.4.1 Novartis Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Novartis Antifungal Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Novartis Antifungal Therapeutics Products Offered
  • 11.4.5 Novartis Recent Development
• 11.5 Roche
  • 11.5.1 Roche Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Roche Antifungal Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Roche Antifungal Therapeutics Products Offered
  • 11.5.5 Roche Recent Development
• 11.6 Sanofi
  • 11.6.1 Sanofi Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Sanofi Antifungal Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Sanofi Antifungal Therapeutics Products Offered
  • 11.6.5 Sanofi Recent Development
• 11.7 Johnson & Johnson
  • 11.7.1 Johnson & Johnson Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Johnson & Johnson Antifungal Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Johnson & Johnson Antifungal Therapeutics Products Offered
  • 11.7.5 Johnson & Johnson Recent Development
• 11.8 Bayer
  • 11.8.1 Bayer Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Bayer Antifungal Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Bayer Antifungal Therapeutics Products Offered
  • 11.8.5 Bayer Recent Development
• 11.9 Bristol-Myers Squibb
  • 11.9.1 Bristol-Myers Squibb Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Bristol-Myers Squibb Antifungal Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Bristol-Myers Squibb Antifungal Therapeutics Products Offered
  • 11.9.5 Bristol-Myers Squibb Recent Development
• 11.10 AbbVie
  • 11.10.1 AbbVie Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 AbbVie Antifungal Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 AbbVie Antifungal Therapeutics Products Offered
  • 11.10.5 AbbVie Recent Development
• 11.11 Eli Lilly
• 11.12 Actavis
• 11.13 Astellas
• 11.14 Teva

12 Future Forecast

• 12.1 Antifungal Therapeutics Market Forecast by Regions
  • 12.1.1 Global Antifungal Therapeutics Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Antifungal Therapeutics Revenue Forecast by Regions 2019-2025
• 12.2 Antifungal Therapeutics Market Forecast by Product
  • 12.2.1 Global Antifungal Therapeutics Sales Forecast by Product 2019-2025
  • 12.2.2 Global Antifungal Therapeutics Revenue Forecast by Product 2019-2025
• 12.3 Antifungal Therapeutics Market Forecast by End User
• 12.4 North America Antifungal Therapeutics Forecast
• 12.5 Europe Antifungal Therapeutics Forecast
• 12.6 Asia Pacific Antifungal Therapeutics Forecast
• 12.7 Central & South America Antifungal Therapeutics Forecast
• 12.8 Middle East and Africa Antifungal Therapeutics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Antifungal Therapeutics Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Antifungal Therapeutics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antifungal Therapeutics market based on company, product type, end user and key regions.

This report studies the global market size of Antifungal Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antifungal Therapeutics in these regions.
This research report categorizes the global Antifungal Therapeutics market by top players/brands, region, type and end user. This report also studies the global Antifungal Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Merck
GSK
Novartis
Roche
Sanofi
Johnson & Johnson
Bayer
Bristol-Myers Squibb
AbbVie
Eli Lilly
Actavis
Astellas
Teva

Market size by Product
Echinacea
Polyene
Pyrimidines
Other
Market size by End User
Hospital
Clinic

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Antifungal Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antifungal Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antifungal Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antifungal Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antifungal Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antifungal Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.